Business Description

Cyanotech Corp. is involved in the commercialization and development of natural products made from microalgae. Gerald R. Cysewski founded the company in 1983. It is headquartered at Kailua-Kona in Hawaii. BioAstin natural antioxidant, which is a dietary anti-inflammatory that supports and maintains the body’s natural immune response to improve eye and skin health, is one of the company’s products. Spirulina Pacifica is a dietary supplement that provides extra energy, cardiovascular benefits an enhanced immune system, and a source for antioxidant carotenoids.

Key Financials

Revenue (US$ Mn):

• US$ 32 Mn was the annual revenue generated by Cyanotech Corp. in 2021
• Cyanotech Corp.’s annual revenue for 2020 was US$ 32 Mn, a 5.6% increase from 2019
• From 2018’s yearly revenues, Cyanotech Corp. registered a -11.46% decrease in 2019, amounting to US$ 30 Mn
• Total revenue of US$ 34 Mn was generated in 2018 by Cyanotech Corp.

Operating Income (US$ Mn):

• Cyanotech Corp.’s operating income for 2021 was US$ 1 Mn, a 31.43% increase from 2020
• The operating income generated by Cyanotech Corp. in 2020 was US$ 1 Mn
• At a -312.06% decrease from , Cyanotech Corp.’s operating income of US$ -3 Mn was indexed in 2019
• Cyanotech Corp. generated an operating income of US$ 1 Mn in 2018

Operating Margin %:

• US$ Mn was the net income generated by Cyanotech Corp. in 2021
• Cyanotech Corp.’s net income for 2020 was US$ 3 Mn, a -133.33% decrease from 2019
• From 2018’s net incomes, Cyanotech Corp. registered a -341.46% decrease in 2019, amounting to US$ -10 Mn
• A net income of US$ 4 Mn was generated in 2018 by Cyanotech Corp.

Gross Margin %:

• Cyanotech Corp.’s operating margin for 2021 was 34%, a -13.57% decrease from 2020
• The operating margin generated by Cyanotech Corp. in 2020 was 40%
• At a -11.48% decrease from , Cyanotech Corp.’s operating margin of 35% was indexed in 2019
• Cyanotech Corp. generated an operating margin of 39% in 2018

SWOT Analysis

Strengths

Financial Performance

A company’s financial performance is better and it can gain investor confidence. It also increases its ability to provide adequate funds for future growth opportunities. The company’s revenue for FY2020 was US$31.9million, compared to US$30.2million in FY2019. This represents an annual growth rate of 5.6%. The increase in extraction services, as well as an increase in spirulina shipments, led to an increase in revenue. The company posted an operating profit in FY2020 of US$1.1million, compared with an operating loss of US$ 3 million in FY2019. In FY2020, it reported a net profit of US$0.4 million, compared with a net loss of US$3.6 million in FY2019.

Get this premium content

The Premium data is Locked

Buy Now to Unlock Premium Data

Request Sample Data